BIOPHYTIS S.A. |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.75 EUR | -1.30% |
|
-5.23% | -63.24% |
| May. 14 | Biophytis unveils design for obesity study | CF |
| May. 14 | Biophytis SA Announces the Design of its Phase 2 OBA Clinical Study in Obesity | CI |
| Sales 2024 * | - | Sales 2025 * | 4.8M 5.2M | Capitalization | 2.17M 2.36M |
|---|---|---|---|---|---|
| Net income 2024 * | -19M -20.6M | Net income 2025 * | -16M -17.35M | EV / Sales 2024 * | - |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.45 x |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 22 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 40.58% |
More Fundamentals
* Assessed data
| 1 day | -1.30% | ||
| 1 week | -5.23% | ||
| Current month | -10.71% | ||
| 1 month | -25.00% | ||
| 3 months | -55.36% | ||
| 6 months | -65.28% | ||
| Current year | -63.24% |
1 week
0.73
0.81
1 month
0.731.04
Current year
0.732.24
1 year
0.7312.80
3 years
0.73423.80
5 years
0.731 092.00
10 years
0.737 720.00
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-23 | 0.75 | -1.30% | 16 701 |
| 24-05-22 | 0.7599 | +2.69% | 46,108 |
| 24-05-21 | 0.74 | -5.13% | 61,066 |
| 24-05-20 | 0.78 | -2.45% | 18,311 |
| 24-05-17 | 0.7996 | +1.04% | 13,125 |
Real-time Euronext Paris, May 23, 2024 at 04:34 am EDT
More quotes
Biophytis S.A. is a biotechnology company in the clinical stage specialized in the development of drug candidates to slow degenerative processes and improve functional capacity in patients with age-related diseases, including respiratory failure in patients suffering from COVID-19.
The company is located in Paris, France and Cambridge, Massachusetts.
Calendar
2024-10-28
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -63.24% | 2.36M | |
| +9.99% | 115B | |
| +12.01% | 106B | |
| -3.07% | 24.69B | |
| -1.11% | 21.97B | |
| -5.20% | 19.27B | |
| -6.90% | 17.56B | |
| -39.36% | 17.32B | |
| +5.82% | 14.03B | |
| +33.05% | 12.13B |
- Stock Market
- Equities
- ALBPS Stock
